BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 11:42:00 AM | Browse: 771 | Download: 827
Publication Name World Journal of Biological Chemistry
Manuscript ID 7485
Country Germany
Received
2013-11-21 11:04
Peer-Review Started
2013-11-21 20:26
To Make the First Decision
2013-12-25 18:13
Return for Revision
2013-12-27 20:41
Revised
2013-12-29 00:25
Second Decision
2014-01-20 08:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-20 09:58
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-02-27 23:05
Typeset the Manuscript
2014-05-19 12:07
Publish the Manuscript Online
2014-06-11 10:30
ISSN 1949-8454 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Biology
Manuscript Type Review
Article Title Endoglin in liver fibrogenesis: Bridging basic science and clinical practice
Manuscript Source Invited Manuscript
All Author List Steffen K Meurer, Muhammad Alsamman, David Scholten and Ralf Weiskirchen
Funding Agency and Grant Number
Funding Agency Grant Number
Deutsche Forschungsgemeinschaft SFB/TRR57 P13
Deutsche Forschungsgemeinschaft SFB/TRR57 P26
Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University IZKF Aachen, Project E6-11 to Weiskirchen R
Corresponding Author Ralf Weiskirchen, Professor, Institute of Clinical Chemistry and Pathobiochemistry, RWTH University Hospital Aachen, Pauwelsstr 30, D-52074 Aachen, Germany. rweiskirchen@ukaachen.de
Key Words Telangiectasia; Signalling; Transforming growth factor-β; Disease; Bleeding disorders
Core Tip Endoglin is an accessory receptor for transforming growth factor-β impacting various aspects of its signaling and biological functions. Endoglin mutations are inherited as autosomal dominant disorders and may cause severe defects in different organs, including brain, lung and liver. In the present review, we will highlight the pathogenesis of several of these disorders and give an overview about the important role of endoglin dysfunction in the pathology of liver fibrosis.
Publish Date 2014-06-11 10:30
Citation Meurer SK, Alsamman M, Scholten D, Weiskirchen R. Endoglin in liver fibrogenesis: Bridging basic science and clinical practice. World J Biol Chem 2014; 5(2): 180-203
URL http://www.wjgnet.com/1949-8454/full/v5/i2/180.htm
DOI http://dx.doi.org/10.4331/wjbc.v5.i2.180
Full Article (PDF) wjbc-5-180.pdf
Full Article (Word) wjbc-5-180.doc
Manuscript File 7585-Review.doc
Answering Reviewers 7485-Answering reviewers.pdf
Copyright License Agreement 7485-Copyright assignment.pdf
Peer-review Report 7485-Peer review(s).pdf
Scientific Editor Work List 7485-Scientific editor work list.doc